Humacyte Stock Price on July 27, 2023
| HUMAW Stock | USD 1.47 0.03 2.00% |
If you're considering investing in Humacyte Stock, it is important to understand the factors that can impact its price. As of today, the current price of Humacyte stands at 1.47, as last reported on the 30th of November, with the highest price reaching 1.64 and the lowest price hitting 1.45 during the day. At this stage we consider Humacyte Stock to be extremely dangerous. Humacyte holds Efficiency (Sharpe) Ratio of 0.0148, which attests that the entity had a 0.0148% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Humacyte, which you can use to evaluate the volatility of the firm. Please check out Humacyte's Market Risk Adjusted Performance of (3.63), risk adjusted performance of (0.02), and Standard Deviation of 7.11 to validate if the risk estimate we provide is consistent with the expected return of 0.1%.
At this time, Humacyte's Liabilities And Stockholders Equity is fairly stable compared to the past year. Stock Based Compensation is likely to climb to about 7.1 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 7.6 M in 2024. . At this time, Humacyte's Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to climb to 0.01 in 2024, despite the fact that Price Earnings Ratio is likely to grow to (2.52). Humacyte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Humacyte |
Sharpe Ratio = 0.0148
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | HUMAW |
| Negative Returns |
Estimated Market Risk
| 7.02 actual daily | 62 62% of assets are less volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 1 99% of assets perform better |
Based on monthly moving average Humacyte is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Humacyte by adding it to a well-diversified portfolio.
Book Value (0.53) | Shares Float 91.3 M | Earnings Share (3.16) | Shares Short 286 |
Related Headline
Celularity Headline on 27th of July 2023
Celularity Inc. and Versa Ophthalmics Announce Exclusive U.S... by news.google.com
Celularity Inc. and Versa Ophthalmics Announce Exclusive U.S. Commercialization Agreement to Distribute Biovance and Biovance 3L Ocular for Ophthalmic Applications Marketscreener.com
Humacyte Valuation on July 27, 2023
It is possible to determine the worth of Humacyte on a given historical date. On July 27, 2023 Humacyte was worth 0.74 at the beginning of the trading date compared to the closed value of 0.69. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Humacyte stock. Still, in general, we apply an absolute valuation method to find Humacyte's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Humacyte where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Humacyte's related companies.
| Open | High | Low | Close | Volume | |
| 0.70 | 0.72 | 0.70 | 0.72 | 719.00 | |
07/27/2023 | 0.74 | 0.75 | 0.68 | 0.69 | 4,937 |
| 0.65 | 0.74 | 0.65 | 0.74 | 12,440 |
| Backtest Humacyte | | | Humacyte History | | | Humacyte Valuation | Previous | Next |
Humacyte Trading Date Momentum on July 27, 2023
| On July 28 2023 Humacyte was traded for 0.74 at the closing time. The highest daily price throughout the period was 0.74 and the lowest price was 0.65 . The daily volume was 12.4 K. The net trading volume on 07/28/2023 added to the next day price increase. The trading delta at closing time to closing price of the next trading day was 7.25% . The trading delta at closing time to current closing price is 14.49% . |
Humacyte Fundamentals Correlations and Trends
By evaluating Humacyte's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Humacyte's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Humacyte financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Humacyte Stock history
Humacyte investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Humacyte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Humacyte will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Humacyte stock prices may prove useful in developing a viable investing in Humacyte
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 103.4 M | 61.4 M |
Humacyte Quarterly Net Working Capital |
|
Humacyte Stock Technical Analysis
Humacyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Humacyte Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Humacyte cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Humacyte November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Humacyte stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Humacyte shares will generate the highest return on investment. By undertsting and applying Humacyte stock market strength indicators, traders can identify Humacyte entry and exit signals to maximize returns
Humacyte Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Humacyte's price direction in advance. Along with the technical and fundamental analysis of Humacyte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Humacyte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (1.47) | |||
| Treynor Ratio | (3.64) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Humacyte Stock Analysis
When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.